Search by Drug Name or NDC
NDC 00641-6023-25 Famotidine 10 mg/mL Details
Famotidine 10 mg/mL
Famotidine is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hikma Pharmaceuticals USA Inc.. The primary component is FAMOTIDINE.
MedlinePlus Drug Summary
Famotidine injection is used in people who are hospitalized to treat certain conditions in which the stomach produces too much acid or to treat ulcers (sores in the lining of the stomach or intestine) that were not successfully treated with other medications. Famotidine injection is also used on a short-term basis in people who cannot take oral medication to treat ulcers, to prevent ulcers from returning after they have healed, to treat gastroesophageal reflux disease (GERD, a condition in which backward flow of acid from the stomach causes heartburn and injury of the esophagus [tube between the throat and the stomach]), and to treat conditions where the stomach produces too much acid, such as Zollinger-Ellison syndrome (tumors in the pancreas and small intestine that caused increased production of stomach acid). Famotidine injection is in a class of medications called H2 blockers. It works by decreasing the amount of acid made in the stomach.
Related Packages: 00641-6023-25Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Famotidine Injection
Product Information
| NDC | 00641-6023 |
|---|---|
| Product ID | 0641-6023_4a84b9ad-8be0-4b70-b5a5-dda3dd3cb934 |
| Associated GPIs | 49200030002020 |
| GCN Sequence Number | 011675 |
| GCN Sequence Number Description | famotidine VIAL 10 MG/ML INTRAVEN |
| HIC3 | Z2D |
| HIC3 Description | HISTAMINE H2-RECEPTOR INHIBITORS |
| GCN | 46410 |
| HICL Sequence Number | 004521 |
| HICL Sequence Number Description | FAMOTIDINE |
| Brand/Generic | Generic |
| Proprietary Name | Famotidine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Famotidine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 10 |
| Active Ingredient Units | mg/mL |
| Substance Name | FAMOTIDINE |
| Labeler Name | Hikma Pharmaceuticals USA Inc. |
| Pharmaceutical Class | Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA075488 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00641-6023-25 (00641602325)
| NDC Package Code | 0641-6023-25 |
|---|---|
| Billing NDC | 00641602325 |
| Package | 25 VIAL in 1 CARTON (0641-6023-25) / 4 mL in 1 VIAL (0641-6023-01) |
| Marketing Start Date | 2001-04-16 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |